SONOMA PHARMACEUTICALS, INC. (SNOA) Free cash flow 2017–2026
SONOMA PHARMACEUTICALS, INC. (SNOA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$4.1MFY2026 · since FY2017: -$8.6M → -$4.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$4.1M | -2355.4% |
| FY2025 | -$168,000 | +93.0% |
| FY2024 | -$2.4M | +62.6% |
| FY2023 | -$6.4M | -46.4% |
| FY2022 | -$4.4M | -23.3% |
| FY2021 | -$3.6M | +25.8% |
| FY2020 | -$4.8M | +59.4% |
| FY2019 | -$11.8M | +6.4% |
| FY2018 | -$12.6M | -47.5% |
| FY2017 | -$8.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SNOA financial trends
SNOA RevenueSNOA Net incomeSNOA Net marginSNOA Gross profitSNOA Gross marginSNOA Operating incomeSNOA Operating marginSNOA Operating cash flowSNOA Capital expendituresSNOA Return on equitySNOA Stock buybacksSNOA Dividends paidSNOA Total assetsSNOA Total liabilitiesSNOA Shareholders’ equitySNOA overview →